Liver transplantation for HCC in cirrhosis: Are Milan criteria outdated?

Michael Linecker,Felix Braun,Jan-Paul Gundlach,Mark Ellrichmann,Marieke van Rosmalen,Serge Vogelaar,Christine Eimer,Corinna Rheinbay,Sabina Rösgen,Jost-Philipp Schäfer,Thomas Becker

DOI: https://doi.org/10.1055/a-2228-7496

2024-01-11

Zeitschrift für Gastroenterologie

Abstract:In Germany, organ allocation is based on the MELD-system and lab-MELD is usually low in patients with hepatocellular carcinoma (HCC) in cirrhosis. Higher medical urgency can be achieved by standard exception for HCC (SE-HCC), if Milan criteria (MC) are met. Noteworthy, UNOS T2 reflects MC, but excludes singular lesions < 2 cm. Thus, SE-HCC is awarded to patients with one lesion between 2 and 5 cm or 2 to 3 lesions between 1 and 3 cm. These criteria are static and do not reflect biological properties of HCC. We present a retrospective cohort of 111 patients, who underwent liver transplantation at UKSH, Campus Kiel between 2007 and 2017. No difference was found in overall survival for patient cohorts using Milan, UCSF, up-to-seven, and French-AFP criteria. However, there was a significantly reduced survival, if microvascular invasion was detected in the explanted organ and in patients with HCC-recurrence. The exclusive use of static selection criteria including MC appear to limit the access to liver transplantation. Die Organallokation zur Lebertransplantation in Deutschland basiert auf dem MELD-System. Patienten mit einem hepatozellulären Karzinom (HCC) in Zirrhose weisen meist einen niedrigen laborchemischen (lab-)MELD auf. Eine Priorisierung der Dringlichkeit auf der Warteliste kann durch eine Standard-Exception (SE-HCC) erfolgen, wenn die Milan-Kriterien (MC) erfüllt sind. Die Richtlinie verwendet UNOS T2, welche MC entsprechen aber singuläre Tumoren unter 2 cm ausschließen. Die Priorisierung erfolgt nach rein statischen Kriterien und berücksichtigt keine weiteren biologischen Tumoreigenschaften. In einer retrospektiven Studie analysierten wir 111 Patienten, die zwischen 2007 und 2017 am UKSH, Campus Kiel, transplantiert wurden. Das Gesamt-Überleben der Patienten unterteilt nach Milan-, UCSF-, up-to-seven- sowie French-AFP-Kriterien zeigte keine signifikanten Unterschiede. Demgegenüber fand sich bei mikrovaskulärer Invasion im Explantat sowie in der Rezidiv-Situation ein signifikant schlechteres Gesamtüberleben. Die ausschließliche Verwendung statischer Selektionskriterien einschließlich MC impliziert einen eingeschränkten Zugang zur Lebertransplantation. Received: 08 September 2023 Accepted after revision: 03 December 2023 Article published online: 09 January 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

gastroenterology & hepatology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate whether the Milan Criteria (MC) are obsolete when hepatocellular carcinoma (HCC) patients undergo liver transplantation. Specifically, the study explored:

1. **The effectiveness of the Milan Criteria**: The Milan Criteria are currently one of the main criteria for selecting HCC patients for liver transplantation. These criteria are based on tumor size and number, limiting the range of patients eligible for liver transplantation. However, with the development of medicine, some studies have suggested that these criteria may be too strict and may exclude some patients who could benefit from liver transplantation.

2. **The effects of other selection criteria**: In addition to the Milan Criteria, the study also compared several other selection criteria, such as the UCSF criteria, the up - to - seven criteria, and the French AFP criteria, to evaluate the effectiveness of these criteria in predicting patient survival rates. These criteria are more lenient in some aspects than the Milan Criteria, but whether they can maintain similar survival rates requires further verification.

3. **The influence of biological characteristics**: The study also explored the influence of the biological characteristics of tumors (such as microvascular invasion and tumor recurrence) on patient survival rates. These characteristics may have an important impact on the prognosis of patients and should therefore be considered when selecting liver transplantation patients.

4. **The combination of static and dynamic selection criteria**: Traditional selection criteria are mostly static, that is, based on tumor size and number. However, the biological response of tumors (such as the response to local treatment) can be used as a dynamic selection criterion, which helps to more accurately select patients suitable for liver transplantation.

By retrospectively analyzing the data of 111 HCC patients who underwent liver transplantation at Kiel University Hospital in Germany between 2007 and 2017, the study aimed to evaluate the patient survival rates under different selection criteria and explore whether the criteria for organ allocation need to be re - defined, especially in patient groups outside the Milan Criteria. The results of the study showed that there were no significant differences in the overall survival rates of patients under different selection criteria, but microvascular invasion and tumor recurrence significantly reduced the patient survival rates. This suggests that more individualized tumor characteristics should be considered when selecting liver transplantation patients.